தங்கம் உயிரி தொழில்நுட்பவியல் கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தங்கம் உயிரி தொழில்நுட்பவியல் கார்ப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தங்கம் உயிரி தொழில்நுட்பவியல் கார்ப் Today - Breaking & Trending Today

Doses, Distance, and Data: The Road to Safe Travel - Taiwan Business TOPICS


Taiwan Business TOPICS
Local pharmaceutical firm Golden Biotechnology Corp. independently developed Antroquinonol
(Hocena®), a novel small-molecule drug, and is now testing its use for treatment of COVID-19. Photo: Golden Biotechnology Corp.
Despite rigorous border control and strict measures, COVID-19 has made its way into Taiwan. Now businesses, researchers, and government are working on innovations that will put Taiwan back in business.
Until recently, Taiwan had a remarkable success record in containing the spread of COVID-19 and maintaining normality for its citizens. While hospitals worldwide had their capacities stretched to their limits, Taiwan reported approximately 1,200 local cases and 11 related deaths in 14 months. However, in May, a few local clusters resulted in a significant spread of the coronavirus around the island. ....

Yang Ming Chiao , Hualian Xian , T Ai Pei , National Taiwan University , Audrey Tang , Antroquinonol Hocena , Antony Lee , Ethan Tu , Paul Torkehagen , Charles Chen , National Yang Ming Chiao Tung University , Ministry Of Health , Ai Lab Tu , Taiwan Ai Lab , National Health Insurance , National Applied Research Laboratories Narlabs , Ministry Of Science , Zai Lab , Drug Administration , Data Monitoring Committee , Narlab National Center , Central Epidemic Command Center , Golden Biotechnology Corp , Medigen Vaccine Biologics Corp , Medigen Vaccine Biologics , United Biomedical ,

COVID-19: US trials for drug made in Taiwan to be expanded

A drug candidate developed by Golden Biotechnology Corp is to enter phase 2 clinical trials patients in the US for treatment of severely ill COVID-19, pending authorization by the authorities, the Taiwanese drugmaker said.
The drug, called antroquinonol, is undergoing phase 2 clinical trials in the US, Peru and Argentina, where 174 hospital patients with mild to moderate COVID-19 symptoms are enrolled in the double-blind placebo study, the company said in statement on Wednesday last week.
Preliminary results of the phase 2 trials in the US were commended by an independent data monitoring committee assigned to the trials by the US ....

Drug Administration , Golden Biotechnology Corp , Golden Biotech , The Taipei Times , தங்கம் உயிரி தொழில்நுட்பவியல் கார்ப் , தி தைப்பே முறை ,